Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dqxLCduTtWCcaEjMCidawyCicNCjxV
| Today's Top Story |  |  | |  | Earn 2X rewards points on shipping costs with The New Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, and shipping
• 1X points on everything else
LEARN MORE AND APPLY |
  - Johns Hopkins signs up Illumina to create asthma risk test
Johns Hopkins researchers received $9.5 million from the National Heart, Lung and Blood Institute to fund its four-year program to map the genomes of 1,000 people in hopes of learning why many African-Americans suffer from the disease. Johns Hopkins has commissioned Illumina to develop a commercially available DNA microarray test to allow researchers to quickly find single mutations that could increase risk for asthma. Genetic Engineering & Biotechnology News (12/30)       - Biomarker test can measure risk, severity of heart attack
A test of the level of muscle tissue protein troponin I could make heart attack diagnosis faster and more accurate, according to a study in the Journal of the American Medical Association. German researchers found that patients with higher levels of troponin appeared to be at increased risk of having a heart attack while changes in troponin levels can help diagnose and determine the severity of myocardial infarction. International Business Times (1/2)  | The Changing Role of Chemistry in Drug Discovery
This Thomson Reuters report delivers an in-depth review of the changing role of Chemistry and of Chemists in today's drug discovery research programs. With input from many key pharmaceutical industry players, supported with data from Thomson Reuters IntegritySM, it examines how life in drug discovery has changed and how it will continue to adapt in the future. Access the report here! |
  | Where there's smoke... Achieving safe and reliable operations with enterprise asset management
Chemical and petroleum companies often view risk management through a limited health, safety and environmental lens, but an IBM Institute for Business Value study reveals a distinct correlation between integrated risk management and market performance. Learn more. |
  | Developments in the Use of PAT and Laboratory Automation
Technical breakthroughs for better understanding and characterization of chemical or biochemical processes are key to meet today’s industry challenges. Integration of process analyzers and process automation with multivariate tools for design, data acquisition and analysis is critical. Register for the webinar. |
 | | | Most Popular Headlines from Last Week Results based on number of times each story was clicked by readers. |
| Food & Agriculture | | | | - Experts: Farming practices may have caused biotech corn resistance
Agricultural practices including failure to rotate crops may have caused rootworms in parts of Iowa to develop resistance to Monsanto's biotech corn, experts say. Scientists suggest crop rotation, exchanging biotech corn varieties, growing new varieties with multiple toxins, applying insecticides to damaged fields and planting patches of traditional corn as a refuge for nonresistant rootworms. USA TODAY/The Associated Press (1/1) | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - Institute streamlines E. coli production of fuel
 Researchers with the Joint Bio-Energy Institute have engineered E. coli bacteria to produce biofuel from plants such as switchgrass, eucalyptus and yard waste. The scientists were able to streamline a multistep process, reducing "costs in half or maybe down to a quarter of what the traditional methods would cost you," said Greg Bokinsky, the project's chief researcher. WCSH-TV (Portland, Maine)/KNTV (San Francisco) (1/2) | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the monthly BIOtechNOW e-newsletter.
| SmartQuote | | | |  | I know of no more encouraging fact than the unquestionable ability of man to elevate his life by conscious endeavor."
--Henry David Thoreau,
American author and poet  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, December 30, 2011
- Thursday, December 29, 2011
- Wednesday, December 28, 2011
- Tuesday, December 27, 2011
- Friday, December 23, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment